Trump administration appoints acting CDC director

Feb. 2, 2018

Anne Schuchat has been tapped to lead the Centers for Disease Control and Prevention following the resignation of the former director Jan. 31.

Dr. Brenda Fitzgerald resigned from the role after Politico reported that she had invested in tobacco stocks after becoming the agency’s director. The CDC carries out a wide range of public heath efforts, including those aimed at smoking cessation. Fitzgerald’s resignation came two days after a new secretary was sworn in to the Department of Health and Human Services, which oversees the CDC and other agencies such as the Food and Drug Administration and the National Institutes of Health.

Schuchat, who was the principal deputy director at CDC, also worked as the acting director when the Trump administration took the helm at the White House in January 2017, until Fitzgerald arrived in July. She has been at the agency since 1988 and has overseen vaccine and bacteria prevention programs. She led the response to the 2009 flu pandemic as well as the response to the SARS outbreak in Beijing in 2003.

HHS said in a statement that Azar accepted Fitzgerald’s resignation because she did not divest from certain financial interests “in a definitive time period.” Fitzgerald had been selected by Tom Price, the former HHS secretary who resigned after Politico reported that tax dollars went toward his private jet travel. Fitzgerald had been the public health commissioner in Georgia, where Price had been a congressman before heading to HHS.

During the last few months, Fitzgerald had to recuse herself from several public health hearings to avoid conflicts of interests associated with her stock holdings. Sen. Patty Murray, D-Wash., had repeatedly raised concerns about that trend.

Washington Examiner has the full article

Sponsored Recommendations

Enhancing Remote Radiology: How Zero Trust Access Revolutionizes Healthcare Connectivity

This content details how a cloud-enabled zero trust architecture ensures high performance, compliance, and scalability, overcoming the limitations of traditional VPN solutions...

Spotlight on Artificial Intelligence

Unlock the potential of AI in our latest series. Discover how AI is revolutionizing clinical decision support, improving workflow efficiency, and transforming medical documentation...

Beyond the VPN: Zero Trust Access for a Healthcare Hybrid Work Environment

This whitepaper explores how a cloud-enabled zero trust architecture ensures secure, least privileged access to applications, meeting regulatory requirements and enhancing user...

Enhancing Remote Radiology: How Zero Trust Access Revolutionizes Healthcare Connectivity

This content details how a cloud-enabled zero trust architecture ensures high performance, compliance, and scalability, overcoming the limitations of traditional VPN solutions...